Functional HRD by RAD51 identi fi es BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents

被引：0

作者：

Casartelli, C. ^{[1
,2
,3
]}

Tommasi, C. ^{[1
,2
,3
]}

Lazzarin, A. ^{[1
,2
,3
]}

Coriano, M. ^{[1
,2
,3
]}

Tornali, C. ^{[1
]}

Serra, O. ^{[1
,2
,3
]}

Campanini, N. ^{[4
]}

Gutierrez-Enriquez, S. ^{[5
]}

Sikokis, A. ^{[2
,3
]}

Zanoni, D. ^{[2
,3
]}

Minari, R. ^{[2
]}

Bortesi, B. ^{[2
]}

Michiara, M. ^{[2
,3
]}

Boggiani, D. ^{[2
,3
]}

Uliana, V. ^{[6
]}

Llop-Guevara, A. ^{[7
]}

Serra, V. ^{[7
]}

Musolino, A. ^{[1
,2
,3
]}

Pellegrino, B. ^{[1
,2
,3
]}

机构：

[1] Univ Parma, Dept Med & Surg, Parma, Italy

[2] Univ Hosp Parma, Med Oncol Unit, Parma, Italy

[3] Grp Oncol Italiano Ric Clin GOIRC, Parma, Italy

[4] Univ Hosp Parma, Pathol Unit, Parma, Italy

[5] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Hereditary Canc Genet Grp, Barcelona, Spain

[6] Univ Hosp Parma, Med Genet Unit, Parma, Italy

[7] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol VHIO, Expt Therapeut Grp, Barcelona, Spain

来源：

ESMO OPEN | 2024年 / 9卷 / 07期

关键词：

D O I：

10.1016/j.esmoop.2024.103629

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 6 条

[1] A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation [J].

Castroviejo-Bermejo, Marta ;

Cruz, Cristina ;

Llop-Guevara, Alba ;

Gutierrez-Enriquez, Sara ;

Ducy, Mandy ;

Hussein Ibrahim, Yasir ;

Gris-Oliver, Albert ;

Pellegrino, Benedetta ;

Bruna, Alejandra ;

Guzman, Marta ;

Rodriguez, Olga ;

Grueso, Judit ;

Bonache, Sandra ;

Moles-Fernandez, Alejandro ;

Villacampa, Guillermo ;

Viaplana, Cristina ;

Gomez, Patricia ;

Vidal, Marc ;

Peg, Vicente ;

Serres-Creixams, Xavier ;

Dellaire, Graham ;

Simard, Jacques ;

Nuciforo, Paolo ;

Rubio, Isabel T. ;

Dientsmann, Rodrigo ;

Barrett, J. Carl ;

Caldas, Carlos ;

Baselga, Jose ;

Saura, Cristina ;

Cortes, Javier ;

Deas, Olivier ;

Jonkers, Jos ;

Masson, Jean-Yves ;

Cairo, Stefano ;

Judde, Jean-Gabriel ;

O'Connor, Mark J. ;

Diez, Orland ;

Balmana, Judith ;

Serra, Violeta .

EMBO MOLECULAR MEDICINE, 2018, 10 (12)

[2]

ClinVar, about us

[3] Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T [J].

Duran-Lozano, Laura ;

Montalban, Gemma ;

Bonache, Sandra ;

Moles-Fernandez, Alejandro ;

Tenes, Anna ;

Castroviejo-Bermejo, Marta ;

Carrasco, Estela ;

Lopez-Fernandez, Adria ;

Torres-Esquius, Sara ;

Gadea, Neus ;

Stjepanovic, Neda ;

Balmana, Judith ;

Gutierrez-Enriquez, Sara ;

Diez, Orland .

BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) :543-550

[4] Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification [J].

Pellegrino, Benedetta ;

Herencia-Ropero, Andrea ;

Llop-Guevara, Alba ;

Pedretti, Flaminia ;

Moles-Fernandez, Alejandro ;

Viaplana, Cristina ;

Villacampa, Guillermo ;

Guzman, Marta ;

Rodriguez, Olga ;

Grueso, Judit ;

Jimenez, Jose ;

Arenas, Enrique J. ;

Degasperi, Andrea ;

Dias, Joao M. L. ;

Forment, Josep, V ;

O'Connor, Mark J. ;

Deas, Olivier ;

Cairo, Stefano ;

Zhou, Yinghui ;

Musolino, Antonino ;

Caldas, Carlos ;

Nik-Zainal, Serena ;

Clarke, Robert B. ;

Nuciforo, Paolo ;

Diez, Orland ;

Serres-Creixams, Xavier ;

Peg, Vicente ;

Espinosa-Bravo, Martin ;

Macarulla, Teresa ;

Oaknin, Ana ;

Mateo, Joaquin ;

Arribas, Joaquin ;

Dienstmann, Rodrigo ;

Bellet, Meritxell ;

Oliveira, Mafalda ;

Saura, Cristina ;

Gutierrez-Enriquez, Sara ;

Balmana, Judith ;

Serra, Violeta .

CANCER RESEARCH, 2022, 82 (08) :1646-1657

[5]

sophiagenetics, SOPHiA DDMTM Dx Hereditary Cancer Solution

[6] Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer [J].

Yadav, Siddhartha ;

Ladkany, Rand ;

Yadav, Dhiraj ;

Alhalabi, Omar ;

Khaddam, Sinan ;

Isaac, Daniel ;

Cardenas, Paola Yumpo ;

Zakalik, Dana .

CLINICAL BREAST CANCER, 2018, 18 (05) :E1229-E1235

← 1 →